Oxford Nanopore Technologies, the company behind a new generation of sequencing-based molecular analysis technologies, and Cepheid, a leading molecular diagnostics company, today announced a strategic ...

Fill out the form below and we'll send your colleague an invitation to the "Integrating Nanopore Sequencing Into Clinical Research: Case Studies in Pathogen, Cancer and Genomics Analysis "event.

Comprehensive maps of mutations in healthy and diseased gastric tissue give clues about how cancer arises ... quality control of sequencing data. Uncalled4 is a toolkit for nanopore signal ...

Understanding of genetic factors that influence prostate cancer and other conditions is expected to improve thanks to a ...

CariGenetics, in collaboration with Oxford Nanopore Technologies, has “launched its Caribbean Genome Programme, the first ...

Like Illumina, it sees major growth opportunities, especially in cancer genomics ... Its focus from the beginning was on nanopore gene sequencing, where DNA is passed through a membrane with ...

Dublin, March 26, 2025 (GLOBE NEWSWIRE) -- The "Nanopore Sequencing Patent Landscape Report and Forecast 2024-2032" report has been added to ResearchAndMarkets.com's offering. The global marketplace ...

Dublin, March 26, 2025 (GLOBE NEWSWIRE) -- The "Nanopore Sequencing Patent Landscape Report and Forecast 2024-2032" report has been added to ResearchAndMarkets.com's offering. The global ...

Oxford Nanopore sequencing reveals rich microbial data by generating complete microbial genomes for outbreak investigations and antimicrobial resistance (AMR) surveillance, as well as food-quality ...

Oxford Nanopore’s chief executive and co-founder Gordon Sanghera told the Financial Times that the gene sequencing company, whose shares have fallen 85 per cent from their 2021 peak, is ...